Mounjaro®
Starting from £179.99/mo
Start journey Learn moreImodium (loperamide) is generally considered safe to use alongside semaglutide for short-term diarrhoea relief, but the decision deserves a moment's thought. Semaglutide slows digestion as part of how it works, which means gut symptoms are common — and reaching for an anti-diarrhoeal without understanding the full picture can occasionally make things worse. There is no blanket interaction that makes the combination dangerous, but your prescriber or pharmacist should know you're taking both. These are prescription-only weight-management medicines that require clinical assessment, so questions about symptom management are always worth raising with the clinical team overseeing your treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide works partly by slowing the rate at which food leaves the stomach. That change in gastric motility is deliberate, it contributes to the sense of fullness that makes eating less feel natural. The downside is that the whole digestive system adjusts at once, and for many people that adjustment comes with loose stools, urgency or outright diarrhoea, especially in the first few weeks on a new dose.
The NHS medicines page for semaglutide lists diarrhoea among the most commonly reported side effects, alongside nausea, vomiting and constipation. Importantly, diarrhoea and constipation can alternate in the same person, the gut is still finding its footing. That alternating pattern is worth keeping in mind before using any anti-diarrhoeal, because the timing can affect which symptom you amplify.
For most people, this phase is temporary. Symptoms tend to be most noticeable in the first week or two after starting or stepping up, then calm down as the body adapts. If they don't settle, that's a signal to speak to your prescriber rather than manage indefinitely with over-the-counter remedies. You can read more about what to expect from treatment on the semaglutide overview page.
There is no clinically documented pharmacokinetic interaction between loperamide and semaglutide. Loperamide acts locally in the gut wall, slowing intestinal movement and reducing fluid loss into the bowel; it is poorly absorbed into the bloodstream. Semaglutide acts via GLP-1 receptors throughout the gut and brain. The two mechanisms don't directly interfere with each other.
So the question shifts from "is this dangerous?" to "is this sensible right now?" A few considerations pull in different directions. First, if diarrhoea is your only symptom and it's mild, it may resolve without any treatment within a couple of days, loperamide might not be necessary. Second, if symptoms are genuinely disruptive, short-term use to get through a difficult few days is reasonable for most adults, and many prescribers would not object. Third, semaglutide already slows gut transit; adding loperamide on top can occasionally tip things sharply toward constipation, which brings its own discomfort. If you want a fuller picture of this specific combination, our page on Imodium and Wegovy covers the considerations in detail, including when short-term use is reasonable and when it isn't. The full guide to medicines that interact with semaglutide covers this broader picture in more detail.
The cleaner decision rule: if diarrhoea is lasting more than two or three days, is accompanied by severe stomach pain, or is causing you to feel faint or very thirsty, that points toward a call to your clinical team rather than a trip to the pharmacy for Imodium.
The MHRA's guidance on GLP-1 medicines flags kidney problems from dehydration as one of the complications of severe or prolonged gastrointestinal illness on these treatments. Diarrhoea causes fluid and electrolyte loss; semaglutide doesn't prevent that. If you're losing fluids quickly, replacing them matters more than stopping the symptom with loperamide.
Practical steps that tend to help: small, frequent sips of water rather than large glasses; oral rehydration sachets if symptoms are significant; avoiding fatty or heavily spiced food for a day or two; and reducing coffee, which can worsen gut motility. These support the body's own recovery rather than suppressing a signal that something needs attention.
If dehydration progresses (if you feel dizzy when standing, stop urinating normally, or feel confused) get medical help the same day. That's true on any GLP-1 treatment, and the MHRA's Yellow Card scheme is where you can report any unexpected side effect if you think it warrants flagging to the regulator. Questions about managing ongoing gut symptoms are exactly the kind of thing the aftercare team at a regulated clinic should be available for, our contact page lists how to reach our clinical team seven days a week.
A single day of loose stools after a dose change is common, manageable and unlikely to need escalating. There are situations, though, where this moves from a self-care decision to a clinical one. If you've been using loperamide regularly for more than a few days to keep symptoms under control, that pattern suggests the dose or the treatment itself needs reviewing, not that you should keep topping up with anti-diarrhoeals.
People sometimes wonder whether questions like this are worth raising, they worry it sounds trivial. It isn't. Gut symptoms are one of the main reasons people pause or stop weight-management treatment, and a small tweak to dose timing, meal composition or hydration strategy can make a significant difference. Our prescribers hear questions like this regularly, and if you've also been unsure about the name of the medicine itself, our guide on how to pronounce semaglutide is there to help you feel confident when talking to a clinician.
If you're considering whether semaglutide-based treatment is right for you, the Wegovy overview page covers the full licensed indication, how treatment is reviewed, and what the process looks like. You can also explore what private weight-loss treatment involves on the weight-loss treatments page. The cost side of things (what a private prescription actually includes) is covered clearly on the Wegovy cost page, if that's a factor in your thinking. When you're ready to talk to a prescriber directly, checking your eligibility takes a few minutes and carries no obligation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.